2024 annual financial data
Neuphoria Therapeutics 2024 Net income growth
Direct answer
Net income growth was 51.86%.
Operating income was -26,786,676 USD and net income was -15,492,166 USD.
Operating cash flow was -14,681,000 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,786,676 USD
- Net income
- -15,492,166 USD
- Operating cash flow
- -14,681,000 USD